Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03401333 · ClinicalTrials.gov registry record · NA
Brief Interventions With Text Messaging to Reduce Adolescent Alcohol and Marijuana Use
A NA study of Alcohol Drinking and Marijuana, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT03401333: Completed NA study of Alcohol Drinking and Marijuana, sponsored by Yale University.
NCT03401333 is a NA study of Alcohol Drinking and Marijuana that has completed, run by Yale University. The registered enrollment target is 10 participants, below the 630-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03401333, a NA study of Alcohol Drinking and Marijuana, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
This study tests the feasibility of an intervention to prevent risky alcohol or marijuana use that adds a 4-week course of tailored text messaging to a brief motivational intervention for 13-18-year-old adolescents.
Primary Outcome
Number of participants per month that enroll in the study
Conditions Studied
Interventions
- BEHAVIORAL Text Messaging and Brief Negotiation Interview
Study Locations (1)
Connecticut
- Yale New Haven Hospital - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2017-11-14 |
| Est. Completion | 2018-06-06 |
| Phase | NA |
What the finished NCT03401333 record still lists
NCT03401333 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 630-participant average among 85 other Alcohol Drinking trials with a reported enrollment target (98% lower).
The record links to 2 conditions, with Alcohol Drinking appearing as the primary indexed condition, and to 1 intervention - of which Text Messaging and Brief Negotiation Interview is the first listed.
NCT03401333 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT03401333 about?
NCT03401333 is a clinical study titled "Brief Interventions With Text Messaging to Reduce Adolescent Alcohol and Marijuana Use". This study tests the feasibility of an intervention to prevent risky alcohol or marijuana use that adds a 4-week course of tailored text messaging to a brief motivational intervention for 13-18-year-old adolescents.
What is the current status of trial NCT03401333?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2017-11-14. Estimated completion is 2018-06-06.
What conditions does trial NCT03401333 study?
This clinical trial studies the following conditions: Alcohol Drinking, Marijuana.
What interventions are being tested in trial NCT03401333?
The interventions under investigation include: Text Messaging and Brief Negotiation Interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT03401333?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03401333 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Drinking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03401333's enrollment target sits among peer trials
10 85th of 85 the lowest of 85 other Alcohol Drinking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Drinking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Alcohol and "Heat of the Moment" Sexual Decision Making
RECRUITING · NA
-
Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers
RECRUITING · NA
-
The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers
RECRUITING · NA
-
Multi-Component Breath Alcohol Intervention Phase 3
RECRUITING · NA
-
Mobile Intervention for Simultaneous Alcohol and Marijuana Use in Young Adults
RECRUITING · NA
-
A SMART Evaluation of an Adaptive Web-based AUD Treatment for Service Members and Their Partners
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI